We took advantage of our CRISPR-mediated RBPMS-knockdown clones to perform RNAseq, observing changes in the expression of several RNA transcripts, including lncRNAs and genes associated with the tumor microenvironment. This evidence concerns the gene RBPMS and neoplasm.